Getein Biotech Inc - Asset Resilience Ratio

Latest as of September 2025: 20.71%

Getein Biotech Inc (603387) has an Asset Resilience Ratio of 20.71% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read 603387 liabilities breakdown for a breakdown of total debt and financial obligations.

Liquid Assets

CN¥794.61 Million

≈ $116.28 Million USD Cash + Short-term Investments

Total Assets

CN¥3.84 Billion

≈ $561.40 Million USD All company assets

Resilience Assessment

Good

Financial Resilience Level

Asset Resilience Ratio Trend (2016–2024)

This chart shows how Getein Biotech Inc's Asset Resilience Ratio has changed over time. See Getein Biotech Inc shareholders equity for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Getein Biotech Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 603387 stock market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥794.61 Million	20.71%
Total Liquid Assets	CN¥794.61 Million	20.71%

Asset Resilience Insights

Good Liquidity Position: Getein Biotech Inc maintains a healthy 20.71% of assets in liquid form.
This level provides good financial flexibility while maintaining productive asset deployment.
The company has significant short-term investments, indicating active treasury management.

Getein Biotech Inc Industry Peers by Asset Resilience Ratio

Compare Getein Biotech Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Demant A/S CO:DEMANT	Medical Devices	-2.59%
Double Medical Technology Inc SHE:002901	Medical Devices	7.79%
Beijing Wandong Medical Technology Co Ltd SHG:600055	Medical Devices	4.92%
Sinocare Inc SHE:300298	Medical Devices	3.53%
MODULIGHT OY EO 1 F:78W	Medical Devices	22.31%
Diagnostic Medical Systems SA PA:ALDMS	Medical Devices	1.39%
Theradiag SA PA:ALTHE	Medical Devices	15.59%
Nova EYE Medical Ltd AU:EYE	Medical Devices	11.08%

Annual Asset Resilience Ratio for Getein Biotech Inc (2016–2024)

The table below shows the annual Asset Resilience Ratio data for Getein Biotech Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	17.50%	CN¥648.88 Million ≈ $94.95 Million	CN¥3.71 Billion ≈ $542.51 Million	+5.52pp
2023-12-31	11.98%	CN¥451.91 Million ≈ $66.13 Million	CN¥3.77 Billion ≈ $551.91 Million	-1.92pp
2022-12-31	13.90%	CN¥511.14 Million ≈ $74.80 Million	CN¥3.68 Billion ≈ $538.12 Million	-5.63pp
2021-12-31	19.52%	CN¥612.68 Million ≈ $89.65 Million	CN¥3.14 Billion ≈ $459.18 Million	-2.51pp
2020-12-31	22.03%	CN¥594.92 Million ≈ $87.06 Million	CN¥2.70 Billion ≈ $395.09 Million	-1.24pp
2019-12-31	23.28%	CN¥467.36 Million ≈ $68.39 Million	CN¥2.01 Billion ≈ $293.78 Million	-26.79pp
2017-12-31	50.07%	CN¥634.14 Million ≈ $92.79 Million	CN¥1.27 Billion ≈ $185.34 Million	+11.58pp
2016-12-31	38.49%	CN¥167.08 Million ≈ $24.45 Million	CN¥434.09 Million ≈ $63.52 Million	--

pp = percentage points

About Getein Biotech Inc

SHG:603387 China Medical Devices

Market Cap

$716.15 Million

CN¥4.89 Billion CNY

Market Cap Rank

#10725 Global

#3156 in China

Share Price

CN¥9.65

Change (1 day)

+5.46%

52-Week Range

CN¥7.65 - CN¥10.65

All Time High

CN¥21.49